The Everstone Group has invested $35 million in Mumbai-based OmniActive Health Technologies Ltd. (OmniActive) to further accelerate its growth in the fast-expanding nutraceuticals space. The deal is Everstone’s third in the healthcare and wellness sector in less than a year.

Both parties will withdraw all legal complaints, cross license each other’s “use patents” and begin to form a Lutein and Zeaxanthin Trade Organization.